## CTSH: Cognizant Technology Solutions  - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.42 indicates fundamental undervaluation. Quality metrics strong (ROA 10%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($74.07)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $82 | $78 | +5% |
| 2025-11-21 | William Blair | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-11-21 | William Blair | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 22 ($0.85M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.8%)
- Blackrock Inc.: 10.5% (-0.2%)
- JPMORGAN CHASE & CO: 8.2% (+108.3%)
- State Street Corpora: 5.2% (-0.9%)
- Pzena Investment Man: 3.7% (+1.5%)

### Key Risks

1. Elevated short interest (8.8%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.42 suggests fair value with growth premium. Forward P/E 13.8x stretched relative to 7% growth. Quality metrics strong (ROA 10%). Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.35), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +5%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.6B |
| Beta | 0.97 |
| 52W Range | $65.15 - $90.82 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.42 |
| Forward P/E | 13.8 |
| Current P/E | 14.7 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.5% over 5 days). Below STRENGTH zone by 0.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. AM_20 at 4.7% shows strong absolute momentum above own 20MA. Outperforming sector by 4.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.62% (CS: 82) | Neutral |
| RSI_14 | 67.7 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.101x | Above |
| vs SMA200 | 1.035x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $77.43
- **Stop Loss:** $74.07 (4.3% risk)
- **Target:** $84.15 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $27,642.51
- **Portfolio %:** 27.64%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-02-04 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.39 | +6.7% |
| 2025Q2 | $1.26 | $1.31 | +4.0% |
| 2025Q1 | $1.20 | $1.23 | +2.5% |
| 2024Q4 | $1.13 | $1.21 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*